Specifically, we further demonstrate that miR-22 inhibits cell migration and invasion via directly inhibiting YWHAZ expression and thus enhances the antitumor activities of the downstream protein, FOXO3a in HCC. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.